Effectiveness of evocalcet for hypercalcemia in patients with primary hyperparathyroidism
Kenichi Tanaka, Yosuke Okada, Kenji Koikawa, Fumi Uemura et autres
jp (code pays fourni par la source)
0 citations
Endocrine Journal
Kenji Koikawa
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
11Publications signalées
122Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Diabetes Treatment and ManagementParathyroid Disorders and TreatmentsCardiovascular Health and Disease PreventionBone health and treatmentsDiabetes, Cardiovascular Risks, and Lipoproteins
Les publications récentes
Two Cases of Painful Thyroiditis With Subsequent Hypothyroidism Following Cord Blood Transplant
Rika Soga, Yosuke Okada, Kenichi Tanaka, Kenji Koikawa et autres
jp (code pays fourni par la source)
0 citations
Cureus
Long-term effects of ipragliflozin on blood pressure in patients with type 2 diabetes: insights from the randomized PROTECT trial
Yuichi Saito, Atsushi Tanaka, Takumi Imai, Ikuko Nakamura et autres
jp (code pays fourni par la source)
7 citations
Hypertension Research
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, Toshihiko Shiraiwa et autres
jp (code pays fourni par la source)
14 citations
Cardiovascular Diabetology
Lack of impact of ipragliflozin on endothelial function in patients with type 2 diabetes: sub-analysis of the PROTECT study
Shinji Kishimoto, Yukihito Higashi, Takumi Imai, Kazuo Fukumoto et autres
jp (code pays fourni par la source)
7 citations
Cardiovascular Diabetology
Effect of ipragliflozin on carotid intima-media thickness in patients with type 2 diabetes: a multicenter, randomized, controlled trial
Atsushi Tanaka, Masataka Sata, Yosuke Okada, Hiroki Teragawa et autres
jp (code pays fourni par la source)
36 citations
European Heart Journal - Cardiovascular Pharmacotherapy
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus
Naoto Katakami, Tomoya Mita, Hidenori Yoshii, Toshihiko Shiraiwa et autres
jp (code pays fourni par la source)
23 citations
Diabetes Therapy
Hyperparathyroidism Which Developed after Resection of a Fibroblast Growth Factor 23-producing Tumor
Kenji Koikawa, Yosuke Okada, Keiichi Torimoto, Yoshiya Tanaka
jp (code pays fourni par la source)
1 citation
Internal Medicine
Type 4B hereditary hemochromatosis due to heterozygous p.D157A mutation in SLC40A1 complicated with hypopituitarism
Yuichi Honma, Tsukasa Karasuyama, Keiichiro Kumamoto, Shohei Shimajiri et autres
jp (code pays fourni par la source)
6 citations
Medical Molecular Morphology
Hyperparathyroidism-jaw Tumor Syndrome Confirmed by Preoperative Genetic Testing
Kenji Koikawa, Yosuke Okada, Hiroko Mori, Mayuko Kawaguchi et autres
jp (code pays fourni par la source)
12 citations
Internal Medicine
Early effects of sodium-glucose co-transporter 2 inhibitors in type 2 diabetes: study based on continuous glucose monitoring
Keiichi Torimoto, Yosuke Okada, Kenji Koikawa, Yoshiya Tanaka
jp (code pays fourni par la source)
16 citations
Diabetology & Metabolic Syndrome
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.